We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
-35.51%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$126M
AUM Growth
-$83.4M
Cap. Flow
-$1.36M
Cap. Flow %
-1.08%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
VVUS
Vivus Inc
VVUS
+$1.22M
2
RCKT icon
Rocket Pharmaceuticals
RCKT
+$142K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$88.3M 70.02%
22,070,213
– –
ALKS icon
2
Alkermes
ALKS
$8.82B
$35.2M 27.95%
1,030,639
– –
VVUS
3
DELISTED
Vivus Inc
VVUS
$2.56M 2.03%
183,000
-113,562
-38% -$1.22M
RCKT icon
4
Rocket Pharmaceuticals
RCKT
$348M
– –
-3,149
Closed -$142K

Similar funds

BHCM
Boulder Hill Capital Management New York $47.9M AUM
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
BHH
Baker Hughes Holdings Houston, Texas $47.6M AUM 26.35% 1-Year Est. Return
LAMC
Lubert-Adler Management Company Philadelphia, Pennsylvania $49.3M AUM 17.46% 1-Year Est. Return
MAM
Miria Asset Management St. Julians, Malta $49.9M AUM 21.84% 1-Year Est. Return
BCM
BlueMar Capital Management Miami, Florida $49.9M AUM 28.76% 1-Year Est. Return
LOF
Lightspeed Opportunity Fund Menlo Park, California $50.1M AUM 53.1% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Meditor Group's Q1 2016 Portfolio in Review

As of Q1 2016, Meditor Group held 4 positions worth $126M, down 40% from $209M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Meditor Group's Q1 2016 filing shows 1 reduced and 1 closed positions. The largest sale was Vivus Inc, an estimated $1.22M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Meditor Group's biggest Q1 2016 reduction was Vivus Inc, cutting an estimated $1.22M.
  • Meditor Group fully exited Rocket Pharmaceuticals in Q1 2016, selling an estimated $142K.
  • Meditor Group's ten largest holdings make up 100% of its $126M portfolio in Q1 2016.
  • Meditor Group opened 0 new positions and closed 1 in Q1 2016.
  • Meditor Group's portfolio value fell 40% quarter-over-quarter to $126M.

Based on Meditor Group's 13F filing for Q1 2016, filed 18 Apr 2016.